Tests blood DNA and scans in early colon cancer surgery
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study looks at a blood test that detects cancer DNA (ctDNA) and compares it with CT scan findings before surgery. It may help doctors understand how aggressive the cancer is and how scan features relate to blood test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a biopsy-confirmed diagnosis of colon (colorectal) cancer
- Your doctors believe you can have surgery with the goal of cure
- Your CT scan shows no spread to distant organs (no metastases)
- You had your pre-surgery staging CT scan within the last 6 weeks
- You are 16 years old or older
- You agree to join by signing informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special blood test to look for traces of tumor DNA (ctDNA) and compares it with information from your original tumor tissue or a new biopsy. It’s done in people with locally advanced rectal cancer who are going to receive standard chemotherapy and radiation, aiming to better track the cancer’s behavior.
This trial is looking at whether a simple blood test (ctDNA monitoring) can help predict how well total neoadjuvant therapy (chemo and radiation before surgery) works for rectal cancer. It may help doctors tailor treatment to your specific needs.
This study looks at whether signs of blood vessel involvement (called EMVI) seen on scans can predict if colorectal cancer spreads to other organs. You might join if you already had surgery to remove the cancer from the colon or rectum and any distant tumors, and your before-surgery scans are available for review.
This trial checks a blood test called circulating tumor DNA to help choose the best time and approach for chemotherapy after colon cancer surgery. It aims to reduce recurrence by identifying people who may benefit from treatment based on changes seen in the blood.
This trial tests whether a blood test that looks at cancer DNA can help decide whether you need “adjuvant” (extra) chemotherapy after colon cancer surgery. It may help some patients avoid unnecessary chemotherapy while still keeping the cancer from coming back.
This study tracks DNA fragments in your blood before, during, and after treatment for stage III colon cancer. It aims to see if these 'ctDNA' and 'TEP' levels can predict how well your tumor responds to neoadjuvant therapy (treatment before surgery).
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.